Registered Kenya · PPB

DIARRAFIN

MONTMORILLONITE

H2008/19245/032 MONTMORILLONITE 3G

What it does

Montmorillonite is a natural clay used to treat various digestive issues.

Commonly used for: diarrhea, gastrointestinal disturbances

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2008/19245/032
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
MONTMORILLONITE
Dosage form
MONTMORILLONITE 3G
Strength
-
Pack size
-
Therapeutic class
-
RxNorm RxCUI
1425919
Manufacturer / MAH
Holley Cotec
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
63 Westlands Rd, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 21:46:06 · updated 2026-03-23 04:31:11

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Montmorillonite is a natural clay used to treat various digestive issues.

What it treats

  • diarrhea
  • gastrointestinal disturbances

How it works

Montmorillonite helps absorb excess fluids and toxins in the gut, which can relieve symptoms of diarrhea.

Who it's for

Adults and children experiencing diarrhea or stomach upset.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: montmorillonite

BNF-referenced

Montmorillonite is a naturally occurring clay mineral that is part of the smectite group. It is primarily composed of aluminum silicate and is known for its ability to absorb water and swell, which makes it useful in various medical applications, particularly in the treatment of gastrointestinal disorders. Its adsorption properties allow it to bind toxins and other substances in the gut, thereby facilitating their excretion.

Indications

  • Diarrhea
  • Gastrointestinal upset
  • Toxin adsorption
  • Acid reflux

Dosage

Children: Refer to the BNF for Children for specific pediatric dosing recommendations, as these will depend on the child's age and weight.

Adults: Refer to the BNF for specific dosing guidelines, as the appropriate dosage may vary based on the condition being treated.

Mechanism of action

The mechanism of action of montmorillonite is not fully understood. However, it has been postulated that it may inhibit certain enzymes, as in vitro studies have shown that low concentrations of bentonite can suppress the activity of human leukocyte elastase, an enzyme that plays a role in the destruction of microorganisms by neutrophils.

Pharmacodynamics

Montmorillonite exhibits its pharmacological effects primarily through its adsorption capacity. It binds to various substances in the gastrointestinal tract, including toxins, pathogens, and excess gastric acid, which can help alleviate symptoms associated with gastrointestinal disorders. Its swelling properties also enhance its surface area, increasing its efficacy as an adsorbent.

Pharmacokinetics

Montmorillonite is not significantly absorbed systemically due to its large particle size and structure. It acts locally within the gastrointestinal tract, where it binds to and facilitates the excretion of various substances. Its effects are primarily seen within the gut, and it does not undergo metabolism or excretion in the traditional sense since it is not absorbed.

Pregnancy

There is limited data on the safety of montmorillonite during pregnancy. Consult a healthcare provider for guidance.

Breast-feeding

Limited information is available on the excretion of montmorillonite in human milk. Consult a healthcare provider for guidance.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

  • Powder
  • Capsules

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: montmorillonite

PubChem CID 71586775

Molecular formula: Al2H2O12Si4

Mechanism of action

The mechanism by which bentonite increases susceptibility is unknown. /Investigators/ however, postulated that enzyme inhibition by bentonite may be a factor, based on their in vitro observation that a low concentration of bentonite can totally suppress the activity of human leukocyte elastase, an enzyme important in the destruction of microorganisms phagocytized by neutrophils.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.